GlassScriptPhysician profile
Michael R Wahl
NPI 1346237807
$5,617.90
in general payments reported to CMS, 2019-2025
36 companies · $44.06 in 2025
The $44.06 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $878 · 2021: $802 · 2022: $555 · 2023: $1,206 · 2024: $692 · 2025: $44.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,942.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $870.12 | 2019-2023 | Watchman Access System |
| Amgen INC. | $708.76 | 2019-2024 | Repatha |
| Philips North America LLC | $541.59 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $511.74 | 2019-2024 | |
| Pfizer INC. | $320.66 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $290.68 | 2019-2023 | Farxiga |
| Merck Sharp & Dohme LLC | $229.49 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $224.01 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.12 | 2019-2023 | Jardiance |
| Sanofi-Aventis U.S. LLC | $210.65 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $168.70 | 2023 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $158.75 | 2023-2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $155.36 | 2019-2023 | Camzyos |
| Amarin Pharma, INC. | $114.35 | 2019-2022 | |
| Abbott Laboratories | $112.43 | 2019-2025 | Aveir |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.